Lori M. Henderson - 11 May 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: General Counsel and Secretary
Signature: /s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 11 May 2021
Net transactions value: -$898,022
Form type: 4
Filing time: 13 May 2021, 16:05:04 UTC
Previous filing: 07 May 2021
Next filing: 14 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise	$9,000	+430	+48%	$20.93^*	1,331	11 May 2021	Direct	F1
transaction	MRNA	Common Stock	Options Exercise	$91,624	+6,170	+464%	$14.85^*	7,501	11 May 2021	Direct	F1
transaction	MRNA	Common Stock	Sale	$998,646	-6,600	-88%	$151.31	901	11 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Stock Option (Right to Buy)	Options Exercise	$0	-430	-0.46%	$0.000000	93,046	11 May 2021	Common Stock	430	$20.93	Direct	F1, F2
transaction	MRNA	Stock Option (Right to Buy)	Options Exercise	$0	-6,170	-1.7%	$0.000000	361,352	11 May 2021	Common Stock	6,170	$14.85	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
F2	25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F3	25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in twelve (12) equal quarterly installments thereafter.